Trial
NCT04643769
Evaluation of Oral ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Phase ISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Orinove, Inc.
Collaborators
Vanderbilt University
Condition
Idiopathic Pulmonary Fibrosis
Intervention
ORIN1001
Why stopped
Partnership activities ongoing
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-30